Diphtheria, tetanus, pertussis and hepatitis-B vaccine (GlaxoSmithKline)

N/A

Report date: 2025/02/10 20:00:43

Base Information

Drug NameDiphtheria, tetanus, pertussis and hepatitis-B vaccine (GlaxoSmithKline)

Drug Alias Name白喉，破伤风，百日咳和乙型肝炎疫苗（葛兰素史克）diphtheria, tetanus, pertussis (whole cell) and hepatitis-B (rDNA) vaccine (adsorbed)Tritanrix HepB

ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsStreptococcal InfectionsTuberculosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBurkina FasoGambia

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsN/A

Inactive IndicationsStreptococcal InfectionsTuberculosis

Other Information

ATC CodeJ07CA05